Lyme disease is commonly evaluated using a blood test that looks for signs your immune system may have responded to exposure. Blood-based testing is the CDC‑recommended approach for laboratory evaluation of Lyme disease.1 This test is collected in person at a patient service center (PSC) and can be scheduled at a time convenient for you.
A Lyme disease blood test may be negative during the first few weeks after infection because your body may not have made enough antibodies yet. For many people, it may take about 2–4 weeks (or longer) after exposure for antibodies to reach levels that a blood test can detect. A healthcare provider can help you determine the most appropriate timing for testing.